University of California San Francisco
Give to UCSF
<p>High blood pressure affects 1 billion people worldwide. At least 30 percent of individual variation in blood pressure is due to genes. The largest-ever study to search for risk genes has just been published and homed in on 16 new genes. But most of the genetic contribution to blood pressure remains elusive. A new research approach may be needed.</p>
A new and simple risk score may aid physicians in gauging the likelihood that a common drug will cause a hemorrhagic stroke or other major bleeding in patients with atrial fibrillation, potentially allowing wider but safer use of the effective drug.
UCSF Medical Center has reduced hospital readmissions for older heart failure patients by nearly a third, thanks to a program designed to identify ways for hospitals to improve patients' transitions to their homes.
Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011.
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
<p>Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. </p>